Do you think BIT is also waiting to complete a commercial transaction for the next announcement? Is BIT negotiating the valuation of our technology to include in the next announcement?
excerpts from the shareholders letter below:
Biotron expects to have data from three such
trials available in the very near term which puts
the Company in a very strong position. These
data, if positive, will be central to successfully
negotiating and completing a commercial
transaction for the Company’s HIV‐1 and
COVID‐19 clinical programs.
$30 Billion Deal, page-1429
-
- There are more pages in this discussion • 3,651 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
